Navigation Links
Dynogen Reports Positive Results in Phase 1B GERD Study

WALTHAM, Mass.--(BUSINESS WIRE)--Jun 7, 2007 - Dynogen Pharmaceuticals, Inc. reported positive results of its randomized, double-blind, placebo-controlled Phase 1b trial of DDP733 for gastroesophageal reflux disease (GERD). The study was designed to demonstrate proof-of-concept for DDP733 as a treatment for nocturnal GERD (NGERD). The 0.5 mg dose of DDP733 achieved statistical significance over placebo on the primary endpoint of reduction in the number of reflux events and was safe and well tolerated. Dynogen is planning to initiate a Phase 2 study of DDP733 in GERD patients in 2008.

DDP733 is an oral, partial agonist of the serotonin type 3 receptor (5-HT(3)), which Dynogen is developing for gastrointestinal conditions such as GERD and irritable bowel syndrome with constipation (IBS-c). In this translational medicine study, healthy volunteers were given a high fat meal to induce gastroesophageal reflux. Reflux events were measured by intraesophageal impedance (the electrical resistance that provides insight into the height and duration of a reflux episode).

"With this second set of positive proof-of-concept data for DDP733, following closely on the heels of our positive Phase 2 data for DDP733 in irritable bowel syndrome with constipation, we've unlocked the potential of this compound as a treatment for two distinct and underserved GI disorders," said Lee R. Brettman, M.D., Chief Executive Officer at Dynogen. "We estimate the peak sales for these indications to be in excess of a billion dollars each, reflecting the significant unmet medical need represented by these disorders. Dynogen has the opportunity to make a real difference in the quality of life of many patients suffering from these disorders."

"We designed this study with the dual goals of obtaining an indication of efficacy and establishing appropriate doses for our later-stage clinical study, and I am pleased to say we accomplished both
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Dynogens DDP733 Reduces Reflux in Phase 1b GERD Study
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dynogen Reports Positive Results Phase GERD Study
(Date:11/28/2014)... LOS ANGELES , Nov. 28, 2014 According ... Americans over the course of their lifetime. For many, these ... chronic pain that is caused by a variety of factors. ... disc, surgery may be the best option. While there are ... Laser Discectomy performed by Seyed M. Rezaian , M.D., ...
(Date:11/28/2014)... Aratana Therapeutics, Inc. (NASDAQ: PETX ), ... acquisition, development and commercialization of innovative biopharmaceutical products for ... it will present at the 26 th Annual ... 2014, at the New York Palace Hotel in ... St. Peter , M.D., President and Chief Executive Officer, ...
(Date:11/27/2014)...  Javon Bea Mercy Health System President ... at Janesville Craig High School and Janesville Parker High ... physicians and Janesville Police and ... Janesville School District. The event ... providing schools and other organizations with the resources needed ...
Breaking Medicine Technology:4 Advantages of Laser Back Surgery When Fixing a Herniated Disk 2Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 3
... COPENHAGEN, November 2 Nuevolution ... derived from its collaboration with,Merck & Co. Inc., Whitehouse ... was triggered following identification of several candidate,molecules that conformed ... original agreement. These include several accepted drug-like,characteristics and nanomolar ...
... In a randomized, double-blind, placebo-controlled trial of 247 patients who ... and liver enzymes; however, vitamin E was more successful for ... associated with fatty liver disease, insulin resistance, and obesity, and ... have NASH. The disease progresses to inflammation in the liver ...
Cached Medicine Technology:Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc. 2Vitamin E Improves NASH 2
(Date:11/28/2014)... Recently, PrettyTailor.com has developed and created its new collection ... world in celebration of the coming holiday season. To ... special offer on all these outfits. Click here ... the garment industry, PrettyTailor.com brings together art and technology ... The business carries quite a few in eye-catching patterns ...
(Date:11/28/2014)... People with diabetes face a number of challenges over the ... expert says. "With the holidays coming, take some time ... family you,ll be visiting and all of the to-dos," Joan ... in an association news release. "By planning ahead. you can ... is to make a healthy eating contract with yourself. Before ...
(Date:11/28/2014)... has been recognized as a leading supplier and exporter ... its new strand woven bamboo flooring collection, ... models. , Based on the website, strand woven bamboo ... It is crafted on strand woven bamboo with a ... work on installation, also available in multiple colors. , ...
(Date:11/28/2014)... Miami, FL (PRWEB) November 28, 2014 ... top cosmetic dermatologists , announced the addition of Dr. ... Dr. Nolan joins the practice after having completed her ... of Medicine. , Dr. Walder invited Dr. Nolan ... training in medicine, surgery and cosmetic dermatology. Not only ...
(Date:11/28/2014)... Dr. Andrew Campbell, one of the ... expansion of Quintessa Aesthetic Center into a third location ... W307 N1497 Golf Road in Suite 200 and will ... the new Delafield location will offer a variety of ... Botox, filler injectables , micro laser peels, chemical ...
Breaking Medicine News(10 mins):Health News:2015 Wedding Dresses from PrettyTailor.com Available Now 2Health News:Holiday Eating Tips for People With Diabetes 2Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2
... , SATURDAY, June 20 (HealthDay News) -- Mowing the ... people forget that their lawn mower can cause serious ... States, about 200,000 people (including 16,000 children) are injured ... Product Safety Commission. Those injuries include severed fingers, toes ...
... 600 Kidney-Friendly Recipes to Meet Kidney Care Needs for Dads ... Inc. (NYSE: DVA ), a leading provider of ... (CKD), offers fathers and their families the opportunity to enjoy ... 600 kidney-friendly recipes available on DaVita.com . ...
... U.S. Senator Amy Klobuchar to visit Healthy Athletes Village and ... Today is the last day to catch Summer Games action ... Klobuchar will visit Healthy Athletes Village today from 9:30-10 a.m. ... from 10-10:30 a.m. at Bierman Field. , , Healthy ...
... imaging equipment is in use in outpatient settings does ... Payment Advisory Commission (MedPAC) recommend Medicare utilize to calculate ... the Radiology Business Management Association (RBMA), a national association ... data, which consist of 261 imaging machines in 46 ...
... , SEATTLE, June 19 /PRNewswire-FirstCall/ -- ... CTIC) today announced the final results of its separate concurrent ... the "Exchange Offers") for any and all of the approximately ... convertible notes (the "Notes"). The Exchange Offers expired at ...
... As President Obama prepares to sign a bill giving ... tobacco industry, a new study from Harvard School of ... continually changed the ingredients and the design of their ... acceptable product variance guidelines. The result, say the researchers, ...
Cached Medicine News:Health News:Don't Get Lazy About Lawn-Mower Safety 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 3Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 2Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 2Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 4Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 2Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 3Health News:Study finds that tobacco companies changed design of cigarettes without alerting smokers 2
... with astigmatism. , If you have astigmatism, ... enjoy a level of comfort unrivaled by ... especially notice the longer you wear your ... of comfort is made possible by PC ...
... lens convenience for those with astigmatism , ... clear vision with the convenience of a ... lenses are manufactured using our patented UltraSync® ... edge on every lens. This lens design ...
The Heine C series binocular loupes offer extremely low weight (46 g), crisp views, and quality German construction in an affordable instrument....
Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work....
Medicine Products: